Lipid metabolism in sarcopenia.

Area of Science:

• Gerontology
• Metabolism
• Skeletal Muscle Physiology

Background:

• Sarcopenia is an age-related geriatric syndrome characterized by muscle mass and strength loss.
• Fat infiltration and altered lipid metabolism in skeletal muscle are hallmarks of aging, type 2 diabetes, and obesity.
• Accumulated lipids, including ceramides, contribute to muscle insulin resistance.

Purpose of the Study:

• To review the regulation of lipid metabolism in skeletal muscle.
• To examine lipid metabolization, storage, and intervention strategies.
• To discuss the role of fatty acids (FAs) and polyunsaturated fatty acids (PUFAs) in sarcopenia.

Main Methods:

• Literature review of studies on lipid metabolism in skeletal muscle.
• Analysis of lipid types and their accumulation in aging and disease states.
• Examination of lipase activity in skeletal muscle for fat breakdown.

Main Results:

• Lipid accumulation, including diacylglycerol, lipid droplets, and intramuscular triglycerides, is evident in sarcopenia.
• Alterations in fatty acid metabolism are linked to muscle insulin resistance and ceramide accumulation.
• Specific lipases are involved in the breakdown of intramuscular triglycerides.

Conclusions:

• Understanding lipid metabolism regulation is crucial for addressing sarcopenia.
• Fatty acids, particularly PUFAs, may offer potential benefits for managing sarcopenia.
• Targeting lipid metabolism presents a therapeutic avenue for age-related muscle decline.